Discovery of a Highly Conserved Peptide in the Iron Transporter Melanotransferrin that Traverses an Intact Blood Brain Barrier and Localizes in Neural Cells
Open Access
- 2 June 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neuroscience
Abstract
The blood-brain barrier (BBB) hinders the distribution of therapeutics intended for treatment of diseases of the brain. Our previous studies demonstrated that that a soluble form of melanotransferrin (MTf; Uniprot P08582; also known as p97, MFI2, and CD228), a mammalian iron-transport protein, is an effective carrier for delivery of drug conjugates across the BBB into the brain and was the first BBB targeting delivery system to demonstrate therapeutic efficacy within the brain. Here, we performed a screen to identify peptides from MTf capable of traversing the BBB. We identified a highly conserved 12-amino acid peptide, termed MTfp, that retains the ability to cross the intact BBB undigested, distribute throughout the parenchyma, and enter endosomes and lysosomes within neurons, astrocytes and microglia in the brain. This peptide may provide a platform for the transport of therapeutics to the CNS, and thereby offers new avenues for potential treatments of neuropathologies that are currently refractory to existing therapies.Funding Information
- Canadian Institutes of Health Research (MOP-133635)
- Natural Sciences and Engineering Research Council of Canada
- National Institutes of Health (1S10OD010756-01A1)
This publication has 62 references indexed in Scilit:
- Identification of helix capping and β-turn motifs from NMR chemical shiftsJournal of Biomolecular NMR, 2012
- Post-Stroke Inhibition of Induced NADPH Oxidase Type 4 Prevents Oxidative Stress and NeurodegenerationPLoS Biology, 2010
- A Unique Carrier for Delivery of Therapeutic Compounds beyond the Blood-Brain BarrierPLOS ONE, 2008
- Blood–brain barrier delivery of protein and non-viral gene therapeutics with molecular Trojan horsesJournal of Controlled Release, 2007
- Transvascular delivery of small interfering RNA to the central nervous systemNature, 2007
- Fusion Antibody for Alzheimer's Disease with Bidirectional Transport Across the Blood−Brain Barrier and Aβ Fibril DisaggregationBioconjugate Chemistry, 2007
- A structural comparison of human serum transferrin and human lactoferrinBioMetals, 2007
- The Crystal Structure of Iron-free Human Serum Transferrin Provides Insight into Inter-lobe Communication and Receptor BindingOnline Journal of Public Health Informatics, 2006
- Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood–brain barrier disruptionProceedings of the National Academy of Sciences of the United States of America, 2006
- Human melanotransferrin (p97) has only one functional iron‐binding siteFEBS Letters, 1992